Document is current
Any future updates will be listed below
-
Authors
Schleimer, Lauren E.
Hakki, Lynn
Seier, Kenneth
Seo, Susan K.
Cohen, Nina
Usiak, Shauna
Romero, Tiffany
Kamboj, Mini
Ilagan, Crisanta
Saadat, Lily V.
Alessandris, Remo
Soares, Kevin C.
Drebin, Jeffrey
Wei, Alice C.
Widmar, Maria
Wei, Iris H.
Joshua Smith, J.
Pappou, Emmanouil P.
Paty, Philip B.
Nash, Garrett M.
Jarnagin, William R.
Garcia-Aguilar, Julio
Gonen, Mithat
Kingham, T. Peter
Weiser, Martin R.
D’Angelica, Michael I.
- License Information
-
More Information
Article History
First Online: 18 December 2024
Disclosures
: Lauren E. Schleimer, Lynn Hakki, Kenneth Seier, Susan K. Seo, Nina Cohen, Shauna Usiak, Tiffany Romero, Mini Kamboj, Crisanta Ilagan, Lily V. Saadat, Remo Alessandris, Kevin C. Soares, Maria Widmar, Iris H. Wei, Emmanouil P. Pappou, Philip B. Paty, Garrett M. Nash, Mithat Gonen, T. Peter Kingham, and Michael I. D’Angelica have no conflicts of interest to declare that may be relevant to the contents of this study. Jeffrey Drebin reports employment and leadership at American Regent (spouse), and stock and other ownership interests in Alnylam, Arrowhead Pharmaceuticals, and Ions Pharmaceuticals. Alice C. Wei reports consulting fees from Histosonics and institutional research funding from Ipsen. J. Joshua Smith reports travel support for fellow education from Intuitive Surgical (19/20 August 2015), serving as a clinical advisor for Guardant Health (19/20 March 2019) and Foundation Medicine (5 April 2022), as a consultant and speaker for Johnson & Johnson (8–10 May 2022), and as a clinical advisor and consultant for GlaxoSmithKline (2023). Julio Garcia-Aguilar reports consulting for Ethicon and Intuitive Surgical. Martin R. Weiser reports consulting for PrecisCa and intellectual property rights for UpToDate.
